Abbott Laboratories is restarting infant formula production at a facility in Michigan. The company shut the Sturgis plant in February after four children became sickened and two died. The closure exacerbated a national shortage of food for very young children. Production will resume on June 20, with the initial product set to reach consumers on or about June 20.
In response to the FDA investigation, it’s said the company has improved sanitation before production to prevent Cronobacter sakazakii (bacteria responsible for the associated illness) from appearing.
The additional production that Abbot can provide will help to alleviate the national shortage. It is also expected that other formulations will soon restart production, upon the completion of all necessary steps set by the FDA.